Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$143,062,624
+$35,443,135 QoQ
Shares Held
568,521
+14.9% QoQ
Ownership
0.032%
of shares outstanding
% of Portfolio
0.82%
of 13F equity value
Holder Rank
#200
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NISSAY ASSET MANAGEMENT CORP /JAPAN holds $652,967,715 across 10 Drug Manufacturers - General names. ABBV ranks #2 (21.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
165,404 | $198,390,536 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
568,521 | $143,062,624 | |
| 3 | JNJ |
Johnson & Johnson
|
335,504 | $85,207,950 | |
| 4 | AMGN |
Amgen Inc
|
159,700 | $57,830,564 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
371,019 | $46,874,540 | |
| 6 | MRK |
Merck & Co., Inc.
|
336,267 | $43,210,309 | |
| 7 | BIIB |
Biogen Inc.
|
185,301 | $40,036,134 | |
| 8 | PFE |
Pfizer Inc
|
795,895 | $19,165,151 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $143,062,624 | 568,521 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $107,619,489 | 494,825 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $98,433,263 | 430,799 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $52,094,879 | 224,993 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $41,466,951 | 223,397 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $46,866,062 | 223,683 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $39,403,198 | 221,740 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $43,373,914 | 219,637 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $37,220,011 | 217,001 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $38,465,711 | 211,234 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $32,706,573 | 211,051 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $31,542,288 | 211,608 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $28,236,309 | 209,577 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $34,883,224 | 218,882 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $36,597,069 | 226,453 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $31,226,372 | 232,668 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $34,511,695 | 225,331 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $34,989,660 | 215,839 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $28,722,537 | 212,131 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $22,327,795 | 206,988 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $22,009,292 | 195,395 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $23,979,712 | 221,583 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $24,206,042 | 225,908 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $17,200,924 | 196,380 | Shares | Sole | 2020-10-20 | |
| 2020-06-30 | $21,371,626 | 217,678 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $12,884,490 | 169,110 | Shares | Sole | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||